Pancreatic Cancer Research

ResearcherNational Institutes of HealthNo recent work listed

Austin G. Duffy

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0001-9277-0157; OpenAlex author ID A5064127666. Sources: ClinicalTrials.gov.

Their work

Papers
4 (first author 2, last author 2)
Trials
1 (principal investigator on 1)
Grants
0
Labs led
0
Collaborators
9
Papers, trials and grants by year

2013: 1 paper · 2014: none · 2015: none · 2016: 1 paper · 2017: none · 2018: none · 2019: none · 2020: 1 paper · 2021: none · 2022: 1 paper · 2023: 1 trial

Papers 4

  1. Targeting KRAS in Pancreatic Cancer. Last author DOI 10.3390/jpm12111870↗
  2. Immune Checkpoint Blockade in Combination with Stereotactic Body Radiotherapy in Patients with Metastatic Pancreatic Ductal Adenocarcinoma. First author DOI 10.1158/1078-0432.ccr-19-3624↗
  3. Targeting the microenvironment of pancreatic cancer: overcoming treatment barriers and improving local immune responses. Last author DOI 10.1007/s12094-015-1459-8↗
  4. Second-line treatment in advanced pancreatic cancer: a comprehensive analysis of published clinical trials. First author DOI 10.1093/annonc/mdt166↗

Trials 1

  1. PaTcH Study: A Phase 2 Study of Trametinib and Hydroxychloroquine in Patients With Metastatic Refractory Pancreatic Cancer Principal investigator NCT05518110↗

Closest collaborators

The 9 strongest of 9 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Darren Cowzer · 1 shared paper, 2022 · strength 0.20
  2. Tim F. Greten · 2 shared papers, 2013–2020 · strength 0.13
  3. Jonathan Matthew Hernandez · 1 shared paper, 2020 · strength 0.09
  4. Freddy E. Escorcia · 1 shared paper, 2020 · strength 0.09
  5. Changqing Xie · 1 shared paper, 2020 · strength 0.09
  6. Jeremy L. Davis · 1 shared paper, 2020 · strength 0.09
  7. Julius Strauss · 1 shared paper, 2016 · strength 0.08
  8. Christine Alewine · 1 shared paper, 2016 · strength 0.08
  9. Osama E. Rahma · 1 shared paper, 2013 · strength 0.05

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.